BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $971,179 | -3.0% | 19,339 | +22.1% | 0.00% | – |
Q2 2023 | $1,001,246 | +63.0% | 15,843 | +16.1% | 0.00% | – |
Q1 2023 | $614,091 | +6.5% | 13,650 | +3.7% | 0.00% | – |
Q4 2022 | $576,583 | -39.2% | 13,161 | -8.6% | 0.00% | -100.0% |
Q3 2022 | $948,000 | +35.2% | 14,393 | +3.8% | 0.00% | – |
Q2 2022 | $701,000 | -12.8% | 13,872 | +10.2% | 0.00% | – |
Q1 2022 | $804,000 | -46.3% | 12,592 | -10.0% | 0.00% | -100.0% |
Q4 2021 | $1,498,000 | -15.2% | 13,985 | -18.6% | 0.00% | 0.0% |
Q3 2021 | $1,767,000 | +21.7% | 17,185 | +4.1% | 0.00% | 0.0% |
Q2 2021 | $1,452,000 | +3.1% | 16,507 | +14.0% | 0.00% | 0.0% |
Q1 2021 | $1,408,000 | +4.5% | 14,485 | +20.5% | 0.00% | 0.0% |
Q4 2020 | $1,348,000 | +35.6% | 12,024 | +12.1% | 0.00% | 0.0% |
Q3 2020 | $994,000 | -16.8% | 10,725 | -29.9% | 0.00% | 0.0% |
Q2 2020 | $1,194,000 | – | 15,302 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |